Reality of Trump’s drug pricing to set in over next 18 months
Vas Narasimhan, chief executive officer of Novartis AG, during an announcement in the Roosevelt Room of the White…
These 4 charts show the scale of Novo Nordisk’s woes
Novo Nordisk was the first company to make a GLP-1 drug for weight loss and became Europe’s most…
Roche Shares Rise After Obesity Drug Shows 18% Greater Weight Loss
This article first appeared on GuruFocus. Roche Holding AG (RHHBY) is beginning to show tangible progress in obesity…
Markets could face ‘everything bubble’ as selloff rages on
Global stocks have fluctuated wildly over the past week, as concerns about AI valuations hang over equity markets.…